You don’t spend almost 30 years as the undisputed expert in long-term cryostorage without gathering a treasure trove of information on the subject. In our extensive bank of articles, blogs, and FAQ’s, you’ll find everything you would want to know about fertility preservation and long-term cryostorage.
Please take a moment to search our blog and articles for any information you may need. If you can’t find it there, your questions may be answered in our FAQ section. In the event that you can’t find what you’re looking for there, please get in touch with us. We’re here to help!
“The doctors said I’d never be able to have children—but I never stopped believing.”
In this deeply personal story, Shanea, a ReproTech team member, shares her path through infertility, recurrent pregnancy loss, and unwavering faith. Despite heartbreak and a complex diagnosis, she found hope in the face of every setback—and joy in the miracle of her son, Joshua.
Read her powerful journey: The Journey to Joshua
At ReproTech, we don’t just cryostore reproductive specimens—we help protect potential futures. In this heartfelt blog post, Holly shares her unique perspective as the daughter of an IVF journey—one of the twin babies her mom welcomed through fertility treatment. Now part of the ReproTech team, she honors that legacy by supporting others on their paths to parenthood.
When ReproTech staff member Jamie was diagnosed with PCOS after several years of trying to conceive, she faced setback after setback—until a new path through IVF gave her and her spouse hope again. This honest and heartfelt story traces the emotional highs and lows of fertility treatment, the strength she discovered in herself, and the arrival of her daughter, Melanie. A moving reminder that even the hardest journeys can lead to something beautiful.
We’re excited to welcome Cristian Milevski as ReproTech’s new Biorepository Manager! With extensive experience as an Andrologist and Embryologist, Cristian brings valuable insight and leadership to our cryostorage operations. His expertise will enhance our services, ensuring the highest level of security and reliability for our clinic partners and their patients.
We asked Cristian a few key questions about his role and how his experience will benefit clinics like yours—read the Q&A below!
ReproTech’s new Scientific Advisory Board will focus on reinforcing the company’s dedication to upholding the highest safety and compliance standards in the cryostorage industry. The Board will provide expert guidance on best practices, regulatory requirements, and innovative approaches to ensure that ReproTech remains the leader in the cryostorage space. This initiative underscores ReproTech’s commitment to protecting the integrity of stored reproductive tissues and maintaining the trust of its clients.
In recognition of Breast Cancer Awareness Month, we’re honored to share Megan’s fertility preservation journey and her decision to trust ReproTech as the long-term cryostorage partner for her precious eggs. Here’s her story:
ReproTech, the industry leader in human reproductive tissue cryogenic storage, has appointed Brad Senstra as Chief Executive Officer. Mr. Senstra brings to ReproTech more than 16 years of experience in fertility and reproductive medicine. Before accepting this position, he served as Executive Director of Seattle Reproductive Medicine (“SRM”). Mr. Senstra is a noted thought leader in reproductive medicine and has presented at numerous American Society for Reproductive Medicine meetings and events over the past 16 years. He also served on the Association of Reproductive Managers Board from 2014-2017. Mr. Senstra earned his Master's of Health Administration from the University of [Read More...]
We at ReproTech are aware of the need for improved access to preserving fertility before cancer treatment and have long partnered with oncologists nationwide to provide an avenue of affordable and safe cryostorage for their patients’ reproductive specimens. Research shows that patients facing fertility-threatening treatments and thus at risk for infertility must be educated about the chances early in treatment planning. UPMC-Magee’s study, published in March 2023, is one of many studies showing a critical need for improved access to fertility preservation for all who want to have a future family following disease recovery.
We’ve launched a new customer portal for an easy, streamlined experience. Invitation emails to existing customers will be rolled out in phases between March 19th and June 30th.
Thank you!